Evidence map›Paper›PMID 33097315›Full record

ArticleJournal of substance abuse treatment2021

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada.

Dennis C Wendt, Stéphanie Marsan, Daniel Parker, Karen E Lizzy, Jessica Roper, Christopher Mushquash, Kamilla L Venner, Alice Lam, Jennifer Swansburg, Nancy Worth and 5 more

Abstract read
In one paragraph

Article in Journal of substance abuse treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Unveiling the link between chronic pain and misuse of opioids and cannabis.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Dennis C WendtDepartment of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: dennis.wendt@mcgill.ca.
Stéphanie MarsanDepartment of Family and Emergency Medicine, Université de Montréal, Centre Hospitalier de l'Université de Montréal, 1051 Sanguinet St., Montreal, Quebec H2X 0C1, Canada. Electronic address: marsan.stephanie@gmail.com.
Daniel ParkerDepartment of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: daniel.parker2@mail.mcgill.ca.
Karen E LizzyCowlitz Tribal Health, 15455 65th Ave S, Tukwila, WA 98188, USA. Electronic address: klizzy@cowlitz.org.
Jessica RoperEskasoni Mental Health Services, 4555 Shore Rd., Eskasoni, Nova Scotia B1W 1K3, Canada. Electronic address: jessicaroper@eskasonihealth.ca.
Christopher MushquashDepartment of Psychology, Lakehead University, 955 Oliver Rd., Thunder Bay, Ontario P7B 5E1, Canada. Electronic address: chris.mushquash@lakeheadu.ca.
Kamilla L VennerDepartment of Psychology, Center on Alcoholism, Substance Abuse, and Addiction, University of New Mexico, 1 University of New Mexico, MSC03 2220, Albuquerque, NM 87131, USA. Electronic address: kamilla@unm.edu.
Alice LamCanadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Centre hospitalier de l'Université de Montréal, CRCHUM - Pavillon R, 900 St-Denis St., Montreal, Quebec H2X 0A9, Canada. Electronic address: alice1.crism@gmail.com.
Jennifer SwansburgCanadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Department of Psychology, Dalhousie University, 1355 Oxford St., P.O. Box 15000, Halifax, Nova Scotia B3H 4R2, Canada. Electronic address: jennifer.crism@gmail.com.
Nancy WorthKahnawake Shakotiia'takehnhas Community Services (KSCS), P.O. Box 1440, Kahnawake, Quebec J0L 1B0, Canada. Electronic address: nancyw@kscskahnawake.ca.
Nicholas SorlagasAlcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105, USA. Electronic address: nicos@uw.edu.
Tania QuachKateri Memorial Hospital Centre (KMHC), 10 River Rd., Kahnawake, Quebec J0L 1B0, Canada. Electronic address: myvanmyvan@gmail.com.
Kristapore ManoukianProxim Pharmacie Kristapore Manoukian, Inc., P.O. Box 2231, Kahnawake, Quebec J0L 1B0, Canada. Electronic address: kristapore@gmail.com.
Payton BernettDepartment of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: payton.bernett@mail.mcgill.ca.
Sandra M RadinAlcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105, USA. Electronic address: sradin@uw.edu.

Funding

Clinical Trials Network: Pacific Northwest Node (CTN-0082, -0131, -0139 and dissemination library)UG1DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI Mary Akiko Hatch, John M. Roll · 2015 to 2026
$19.8M
NIDA NIH HHS UG1 DA013714
6 · The paper itself

Abstract

This commentary focuses on how some Indigenous communities in the United States (U.S.) and Canada are addressing the opioid epidemic within the context of the COVID-19 pandemic, from the perspective of the co-authors as researchers, clinicians, and pharmacists working within or among Indigenous communities in three eastern Canadian provinces and two western U.S. states. The pandemic has likely exacerbated opioid use problems among Indigenous communities, especially for individuals with acute distress or comorbid mental illness, or who are in need of withdrawal management or residential services. In response to the pandemic, we discuss first how greater prescription flexibility has facilitated and even increased access to medications for opioid use disorder. Second, we describe how Indigenous-serving clinics have expanded telemedicine services, albeit not without some challenges. Third, we note challenges with restricted participation in traditional Indigenous healing practices that can be helpful for addiction recovery. Fourth, we mention providers' worries about the pandemic's impact on their patients' mental health and safety. We argue that certain treatment transformations may be helpful even after the pandemic is over, through enhancing access to community-grounded treatment, decreasing stigma, and promoting patient self-efficacy.

Indexed as

COVID-19Indigenous PeoplesOpiate Substitution TreatmentPractice Patterns, Physicians'TelemedicineBuprenorphineCanadaHumansMental HealthNarcotic AntagonistsOpioid-Related DisordersUnited StatesBuprenorphineNarcotic AntagonistsCOVID-19Indigenous PeoplesMedication for opioid use disorderOpioid-agonist treatmentOpioid use disorderTelemedicine

Identifiers

PMID33097315
PMCPMC7546255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.